Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Gisbert

Showing results (51-60 of 317) with videos related to

Pageof 32
Sort By:
Alimentary Pharmacology & Therapeutics|June 19, 2012
Letter: TPMT - not all that glitters is goldY González-Lama, J P Gisbert
Alimentary Pharmacology & Therapeutics|June 3, 2016
Letter: oral low-dose methotrexate for collagenous colitis - authors' replyF Fernández-Bañares, J P Gisbert
Alimentary Pharmacology & Therapeutics|December 1, 2004
Review article: 13C-urea breath test in the diagnosis of Helicobacter pylori infection -- a critical reviewJ P Gisbert, J M Pajares
Alimentary Pharmacology & Therapeutics|June 19, 2013
Commentary: overcoming antibiotic resistance with Helicobacter pylori therapy--optimisation is the way forwardJ Molina-Infante, J P Gisbert
Revista Espanola De Enfermedades Digestivas|August 8, 2001
Epidemiology of inflammatory bowel disease in Spain. A systematic reviewJ M Pajares, J P Gisbert
Alimentary Pharmacology & Therapeutics|May 29, 2002
Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies failJ P Gisbert, J M Pajares
Medicina Clinica|August 2, 2001
[Bleeding peptic ulcer. Can the prognosis be accurately estimated and the hospitalization prevented?]J P Gisbert, J M Pajares
Revista Espanola De Enfermedades Digestivas|October 7, 2006
Gastric angiogenesis and Helicobacter pylori infectionI D Pousa, J P Gisbert
Acta Gastroenterologica Latinoamericana|February 2, 1999
[Are there "good" H. pylori and "bad" H. pylori?/]J P Gisbert, J M Pajares
Alimentary Pharmacology & Therapeutics|September 3, 2015
Letter: sitafloxacin for H. pylori infection in Japan: considerations on resistance rates, generalisability and its place in the therapeutic algorithmJ Molina-Infante, J P Gisbert
Pageof 32

Showing results (51-60 of 317) with videos related to

Sort By:
Pageof 32
Alimentary Pharmacology & Therapeutics|June 19, 2012
Letter: TPMT - not all that glitters is goldY González-Lama, J P Gisbert
Alimentary Pharmacology & Therapeutics|June 3, 2016
Letter: oral low-dose methotrexate for collagenous colitis - authors' replyF Fernández-Bañares, J P Gisbert
Alimentary Pharmacology & Therapeutics|December 1, 2004
Review article: 13C-urea breath test in the diagnosis of Helicobacter pylori infection -- a critical reviewJ P Gisbert, J M Pajares
Alimentary Pharmacology & Therapeutics|June 19, 2013
Commentary: overcoming antibiotic resistance with Helicobacter pylori therapy--optimisation is the way forwardJ Molina-Infante, J P Gisbert
Revista Espanola De Enfermedades Digestivas|August 8, 2001
Epidemiology of inflammatory bowel disease in Spain. A systematic reviewJ M Pajares, J P Gisbert
Alimentary Pharmacology & Therapeutics|May 29, 2002
Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies failJ P Gisbert, J M Pajares
Medicina Clinica|August 2, 2001
[Bleeding peptic ulcer. Can the prognosis be accurately estimated and the hospitalization prevented?]J P Gisbert, J M Pajares
Revista Espanola De Enfermedades Digestivas|October 7, 2006
Gastric angiogenesis and Helicobacter pylori infectionI D Pousa, J P Gisbert
Acta Gastroenterologica Latinoamericana|February 2, 1999
[Are there "good" H. pylori and "bad" H. pylori?/]J P Gisbert, J M Pajares
Alimentary Pharmacology & Therapeutics|September 3, 2015
Letter: sitafloxacin for H. pylori infection in Japan: considerations on resistance rates, generalisability and its place in the therapeutic algorithmJ Molina-Infante, J P Gisbert
Pageof 32